Clinical Trials Directory

Trials / Completed

CompletedNCT04363970

Early Removal of the Urethral Catheter Following Trans-urethral Resection of Prostate

Early Versus Delayed Removal of the Urethral Catheter After Trans Urethral, Randomized Clinical Trial.

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
University of Jordan · Academic / Other
Sex
Male
Age
45 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Transurethral resection of prostate is the gold standard operation for bladder outflow obstruction due to benign prostatic enlargement. However, catheter removal day is variable. The objective of this study is to compare early and delayed catheter removal groups in terms of, urinary retention after catheter removal, length of hospital stay, weight of resected prostate, duration of resection, peri-operative blood transfusion, and postoperative complications.

Detailed description

This randomized controlled trial will carried out in Urology clinic at Jordan university hospital. Patients with benign prostate hyperplasia will be selected by simple random sampling technique after taking informed consent and will divided into two groups: Group A- early catheter removal group( catheter removed after 24 hours) and Group B-delayed catheter removal group ( catheter removed after 48 hours). in this study we will exclude patients with large post-void urine volume, simultaneous internal urethrotomy and transurethral resection of prostate, co-morbidity( diabetes mellitus, CVA) spinal cord injury, urethral stricture, prostate cancer proved by biopsy and intra-operative complications. Patients will discharged after removal of catheter if they voided successfully.

Conditions

Interventions

TypeNameDescription
OTHERremoval of the urinary catheterin group A, we will remove the catheter after 24 h. In group B, we will remove the catheter after 48 h.

Timeline

Start date
2019-06-30
Primary completion
2020-04-30
Completion
2021-04-30
First posted
2020-04-27
Last updated
2021-08-20

Locations

1 site across 1 country: Jordan

Source: ClinicalTrials.gov record NCT04363970. Inclusion in this directory is not an endorsement.